Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-Derived Growth Factors to Enhance Healing and Reduce Post-Extraction Complications in Smokers
NCT07364890Active, not recruiting
- Sponsor
- King Abdulaziz University
- Start
- Feb 2026
- Primary completion
- Sep 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial of advanced platelet-rich fibrin in Post-extraction complications (2 arms), sponsored by King Abdulaziz University. Primary endpoint: Socket size using intra-oral scan at 3 weeks. Started Feb 2026; status: active, not recruiting.
02
Drugs
advanced platelet-rich fibrin
03
Conditions
Post-extraction complications
Beyond the preview
Go deeper on NCT07364890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07364890.